Changes in PRMT4, mainly upregulation, are frequently reported in various types of human cancers, including breast cancer 18, lung cancer 17, colorectal cancer 19, and prostate cancer 20, which appears to promote cancer initiation, progression and metastasis. This evidence concerns the gene CARM1 and breast carcinoma.